Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FERM, RhoGEF and pleckstrin domain-containing protein 1 (FARP1) is a multi-domain cytoplasmic protein containing a FERM domain, a Dbl homology (DH) domain, and two pleckstrin homology (PH) domains. It functions as a postsynaptic guanine nucleotide exchange factor, primarily activating the Rac1 GTPase, to regulate cytoskeletal dynamics and promote dendritic growth, synapse formation, and dendritic spine development in neurons. FARP1 interacts with cell surface proteins, including SynCAM 1 and PlexinA family receptors, via its FERM domain to mediate membrane localization and signal transduction. In addition to its critical role in neural development and synaptic organization, FARP1 also influences cell motility and invasion in non-neuronal cells by modulating Rho GTPase activity, with implications in cancer biology. Multiple transcript variants exist for this gene, and its dysfunction is associated with diseases such as cancer and congenital nystagmus. Note: - No small-molecule drug modulators, patient biomarkers, or well-established adverse safety concerns in the clinical context for FARP1 are documented in current literature. - FARP1 belongs primarily to the guanine nucleotide exchange factor family and adapter proteins with emphasis on neural and oncogenic contexts. - This entry is specific, correctly capitalized, and well-defined according to standard molecular nomenclature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FERM, RhoGEF and pleckstrin domain-containing protein 1 (FARP1).